Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
Main Authors: | Chowdhury, O, O’Sullivan, J, Barkas, N, Wang, G, Buck, G, Hamblin, A |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Springer Nature
2020
|
פריטים דומים
-
Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
מאת: Chowdhury, O, et al.
יצא לאור: (2018) -
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
מאת: Bing Li, et al.
יצא לאור: (2017-05-01) -
Mechanisms of disease transformation in myeloproliferative neoplasms
מאת: O'Sullivan, J
יצא לאור: (2022) -
Heterogeneity in myeloproliferative neoplasms: causes and consequences
מאת: O'Sullivan, J, et al.
יצא לאור: (2018) -
Profile of pomalidomide and its potential in the treatment of myelofibrosis
מאת: Gowin KL, et al.
יצא לאור: (2015-04-01)